Analysis of the Androgen Binding in Human Benign Prostatic Hypertrophy

References

• Shain S. A., Gorelic L. S., Boesel R. W., Radwin H. M., Lamm D. L. Human prostate androgen receptor quantitation: effects of temperature on assay parameters. Cancer Res. 1982; 42: 4849–4854
   Google Scholar
• Wilbert D. M., Griffin J. E., Wilson J. D. Characterization of the cytosol androgen receptor of the human prostate. J. Clin. Endocrinol. Metab. 1983; 56: 113–120
   Google Scholar
• Smith T., Sutherland F., Chisholm G. D., Habib F. K. Factors affecting the reproducibility of androgen receptor determinations in human prostate. Clin. Chim. Acta 1983; 131: 129–141
   Google Scholar
• Barrack E. R., Bujnovszky P., Walsh P. C. Subcellular distribution of androgen receptors in human normal, benign hyperplastic, and malignant prostatic tissues: characterization of nuclear salt‐resistant receptors. Cancer Res. 1983; 43: 1107–1116
   PubMed Web of Science ®Google Scholar
• Hawkins E. F., Nijs M., Brassinne C. Steroid receptors in the human prostate. Detection of tissue‐specific androgen binding in prostate cancer. Clin. Chim. Acta 1977; 75: 303–312
   Google Scholar
• Wagner R. K. Characterization and assay of steroid hormone receptors and steroid‐binding serum proteins by agar gel electrophoresis at low temperature, Hoppe‐Seyler's. Z. Physiol. Chem. 1972; 353: 1235–1245
   Google Scholar
• Chamness G. C., McGuire W. L. Scatchard plots: common errors in correction and interpretation. Steroids 1975; 26: 538–542
   PubMed Web of Science ®Google Scholar
• Scatchard G. The attractions of proteins for small molecules and ions. Ann. N.Y. Acad. Sci. 1949; 51: 660–672
   Web of Science ®Google Scholar
• Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Brassinne C., Coune A., Nijs M., Tagnon H. J. Characterization of two direct fibrinogenolytic activities and of one proteolytic inhibitor activity in the human prostate. Thromb. Res. 1976; 8: 803–818
   PubMed Web of Science ®Google Scholar
• Catt K. J. Endocrinology and Metabolism second edition, P. Felig, J. D. Baxter, A. E. Broadus, L. A. Frohman. McGraw‐Hill, New York, NY 1987; 82–165
   Google Scholar
• Fang S., Liao S. Steroid‐ and tissue‐specific retention of a 17β‐hydroxy‐5α‐androstan‐3–one‐protein complex by the cell nuclei of ventral prostate. J. Biol. Chem. 1971; 246: 16–24
   PubMed Web of Science ®Google Scholar
• Katsumata M., Goldman A. S. Separation of multiple dihydrotestosterone receptors in rat ventral prostate by a novel micromethod of electrofocusing. Blocking action of cyproterone acetate and uptake by nuclear chromatin. Biochim. Biophys. Acta 1974; 359: 112–129
   Google Scholar
• Pertschuk L. P., Eisenberg K. B., Macchia R. J., Feldman J. G. Heterogeneity of steroid binding sites in prostatic carcinoma: morphological demonstration and clinical implications. The Prostate 1985; 6: 35–47
   Google Scholar
• Bevins C. L., Bashirelahi N. Stabilization of 8S progesterone receptor from human prostate in the presence of molybdate ion. Cancer Res. 1980; 40: 2234–2239
   Google Scholar
• Prins G. S., Lee C. Effect of protease inhibitors on androgen receptor analysis in rat prostate cytosol. Steroids 1982; 40: 189–201
   Google Scholar
• Gase J. ‐M., Baulieu E. ‐E. Steroid hormone receptors: intracellular distribution. Biol. Cell. 1986; 56: 1–6
   Google Scholar
• Mobbs E. G., Johnson I. E., Connolly J. G., Thompson J. Concentration and cellular distribution of androgen receptor in human prostatic neoplasia: can estrogen treatment increase androgen receptor content?. J. Steroid Biochem. 1983; 19: 1279–1290
   PubMedGoogle Scholar
• Radwan F., Léger F., Carmel M., Elhilali M., Lehoux J. ‐G. Characterization of androgen receptors in normal and malignant human prostatic tissues. The Prostate 1986; 9: 147–158
   Google Scholar
• Benson R. C., Jr., Utz D. C., Holicky E., Veneziale C. M. Androgen receptor binding activity in human prostate cancer. Cancer 1985; 55: 382–388
   Google Scholar
• Mann T. The biochemistry of semen and of the male reproductive tract. Methuen & Co LTD, London 1964, John Wiley & Sons INC., New York, N.Y.
   Google Scholar
• Bonne C., Raynaud J. ‐P. Methyltrienolone, a specific ligand for cellular androgen receptors. Steroids 1975; 26: 227–232
   PubMed Web of Science ®Google Scholar
• Shimazaki J., Hikage T., Sato R., Kodama T., Ito H. Measurement of androgen receptors in cytosols from normal, benign hypertrophic and cancerous human prostates. Endocrinol. Japon. 1981; 28: 725–734
   Google Scholar
• de Larminat M. A., Pasik L., Bellora O., Arturi J., Scorticati C. Increased recovery of androgen receptors from human prostate through the use of mersalyl: evidence for androgen regulation of the binding sites in carcinomatous prostate. The Prostate 1986; 9: 97–108
   Google Scholar
• Mobbs B. G., Johnson I. E., Connolly J. G., Clark A. F. Androgen receptor assay in human benign and malignant prostatic tumour cytosol using protamine sulfate precipitation. J. Steroid Biochem. 1978; 9: 289–301
   Google Scholar
• Kodama T., Hasebe C., Shimazaki J. Binding to R 1881 (methyltrienolone) of proteins from human benign prostatic hypertrophy. Endocrinol. Japon 1980; 27: 229–237
   Google Scholar
• Traish A. M., Müller R. E., Wotiz H. H. Differences in the physicochemical characteristics of androgen‐receptor complexes formed in vivo and in vitro. Endocrinol. 1984; 114: 1761–1769
   Google Scholar
• Bashirelahi N., Felder C. C., Young J. D. Characterization and stabilization of progesterone receptors in human benign prostatic hypertrophy. J. Steroid Biochem. 1983; 18: 801–809
   Google Scholar
• Cowan R. A., Cowan S. K., Grant J. K. Binding of methyltrienolone (R1881) to a progesterone receptor‐like component of human prostatic cytosol. J. Endocrinol. 1977; 74: 281–289
   Google Scholar
• Hawkins E. F., Nijs M., Brassinne C., Mattheiem W. H. Enigmatic binding of corticosterone to protein in cytosols of human benign prostatic hypertrophy tissue. J. Endocrinol. 1975; 69: 17P–18P
   Google Scholar
• Shain S. A., Boesel R. W., Lamm D. L., Radwin H. M. Characterization of unoccupied (R) and occupied (RA) androgen binding components of the hyperplastic human prostate. Steroids 1978; 31: 541–556
   PubMed Web of Science ®Google Scholar
• Ekman P., Snochowski M., Dahlberg E., Bression D., Högberg B., Gustafsson J. ‐A. Steroid receptor content in cytosol from normal and hyperplastic human prostates. J. Clin. Endocrinol. Metab. 1979; 49: 205–215
   PubMedGoogle Scholar
• Trachtenberg J., Hicks L. L., Walsh P. C. Methods for the determination of androgen receptor content in human prostatic tissue. Invest. Urol. 1981; 18: 349–354
   PubMedGoogle Scholar
• Brendler C. B., Isaacs J. T., Follansbee A. L., Walsh P. C. The use of multiple variables to predict response to endocrine therapy in carcinoma of the prostate: a preliminary report. J. Urol. 1984; 131: 694–700
   Google Scholar
• Fentie D. D., Lakey W. H., McBlain W. A. Applicability of nuclear androgen receptor quantification to human prostatic adenocarcinoma. J. Urol. 1986; 135: 167–173
   Google Scholar
• Habib F. K., Odoma S., Busuttil A., Chisholm G. D. Androgen receptors in cancer of the prostate. Correlation with the stage and grade of the tumor. Cancer 1986; 57: 2351–2356
   Google Scholar